Suppr超能文献

将乳腺癌相关淋巴水肿的前瞻性监测和早期干预护理模式付诸临床实践:RE-AIM 框架的应用。

Implementing a prospective surveillance and early intervention model of care for breast cancer-related lymphedema into clinical practice: application of the RE-AIM framework.

机构信息

Australian Lymphoedema Education, Research and Treatment (ALERT) Program, Department of Clinical Medicine, Faculty of Medicine, Health & Human Sciences, Macquarie University, Sydney, Australia.

Vanderbilt University School of Nursing, Nashville, TN, USA.

出版信息

Support Care Cancer. 2021 Feb;29(2):1081-1089. doi: 10.1007/s00520-020-05597-5. Epub 2020 Jun 29.

Abstract

PURPOSE

Chronic lymphedema following breast cancer (BC) affects individuals physically, functionally, psychologically, and financially. Despite national guidelines and evidence-based research supporting a prospective surveillance and early intervention model of care (PSM), bridging the gap between research and clinical practice has been difficult.

METHOD

As part of an international randomized controlled trial (RCT), Australian women with BC from four hospitals were recruited, monitored for lymphedema at regular intervals over a 3-year period, and were provided a compression garment if intervention was triggered. The reach, effectiveness, adoption, implementation and maintenance (RE-AIM) evaluation framework was used retrospectively to assess a PSM at the individual and organizational level for those who had completed at least 2-year follow-up (N = 219) in the RCT.

RESULTS

The application of the RE-AIM framework retrospectively demonstrated an extensive reach to patients across public and private settings; the effectiveness of prospective surveillance and early intervention was achieved through low progression rates to clinical lymphedema (1.8%), and all hospital sites initially approached adopted the research study. Key implementation strategies necessary for effectiveness of this model of care included education to health professionals and patients, staff acceptability, and development of a referral and care pathway. Maintenance dimensions were evaluated both at the individual level with 92-100% adherence rates for all nonoptional study appointments over the 2-year period, and at the organizational-level, PSM was sustained after recruitment ceased for the research study.

CONCLUSION

The PSM for lymphedema in BC can be successfully implemented using the RE-AIM framework applied retrospectively. The implementation of the PSM used in the RCT has assisted in changing clinical practices and improving the quality and effectiveness of the health care system.

摘要

目的

乳腺癌(BC)后慢性淋巴水肿会对个人的身体、功能、心理和经济造成影响。尽管有国家指南和基于证据的研究支持前瞻性监测和早期干预护理模式(PSM),但研究与临床实践之间的差距一直难以弥合。

方法

作为一项国际随机对照试验(RCT)的一部分,来自四家医院的澳大利亚 BC 女性患者被招募,在 3 年内定期监测淋巴水肿情况,如果需要干预则提供压缩服装。采用 RE-AIM 评估框架(范围、有效性、采用、实施和维持),对完成至少 2 年 RCT 随访的患者(N=219)进行个体和组织层面的 PSM 评估。

结果

RE-AIM 框架的应用回顾性地表明,该框架广泛覆盖了公共和私人环境中的患者;前瞻性监测和早期干预的有效性通过临床淋巴水肿进展率低(1.8%)得以实现,并且所有最初接触的医院都采用了该研究。为了实现这种护理模式的有效性,关键的实施策略包括对卫生专业人员和患者进行教育、工作人员的可接受性以及转诊和护理途径的开发。维持维度在个体层面进行评估,所有非选择性研究预约的 2 年内,患者的依从率为 92-100%,在组织层面,在研究招募结束后,PSM 得以维持。

结论

可以使用回顾性应用的 RE-AIM 框架成功实施 BC 淋巴水肿的 PSM。RCT 中使用的 PSM 的实施有助于改变临床实践,并提高医疗保健系统的质量和效果。

相似文献

2
Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
Breast Cancer Res Treat. 2023 Feb;198(1):1-9. doi: 10.1007/s10549-022-06850-7. Epub 2022 Dec 24.
5
Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
J Cancer Surviv. 2024 Apr;18(2):344-351. doi: 10.1007/s11764-022-01242-8. Epub 2022 Aug 10.
8
The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review.
Cancer Med. 2016 Jun;5(6):1154-62. doi: 10.1002/cam4.691. Epub 2016 Mar 19.

引用本文的文献

2
Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program.
Front Oncol. 2024 Jul 16;14:1418610. doi: 10.3389/fonc.2024.1418610. eCollection 2024.
3
Comparison of Volume Measurements and Bioimpedance Spectroscopy Using A Stand-on Device for Assessment of Unilateral Breast Cancer-Related Lymphedema.
Eur J Breast Health. 2024 Apr 1;20(2):141-148. doi: 10.4274/ejbh.galenos.2024.2023-12-8. eCollection 2024 Apr.
5
Advances in the prevention and treatment of breast cancer-related lymphedema.
Breast Cancer Res Treat. 2023 Jul;200(1):1-14. doi: 10.1007/s10549-023-06947-7. Epub 2023 Apr 27.
6
Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
Breast Cancer Res Treat. 2023 Feb;198(1):1-9. doi: 10.1007/s10549-022-06850-7. Epub 2022 Dec 24.
9
A COVID-19 Rehabilitation Prospective Surveillance Model for Use by Physiotherapists.
J Clin Med. 2021 Apr 14;10(8):1691. doi: 10.3390/jcm10081691.

本文引用的文献

8
Leveraging Implementation Science to Improve Cancer Care Delivery and Patient Outcomes.
J Oncol Pract. 2017 Aug;13(8):523-529. doi: 10.1200/JOP.2017.024729. Epub 2017 Jul 10.
10
Financial cost of lymphedema borne by women with breast cancer.
Psychooncology. 2017 Jun;26(6):849-855. doi: 10.1002/pon.4239. Epub 2016 Aug 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验